Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Combination PD-1 and PD-L1 Blockade Promotes Durable Neoantigen-Specific T Cell-Mediated Immunity in Pancreatic Ductal Adenocarcinoma.

Burrack AL, Spartz EJ, Raynor JF, Wang I, Olson M, Stromnes IM.

Cell Rep. 2019 Aug 20;28(8):2140-2155.e6. doi: 10.1016/j.celrep.2019.07.059.

2.

Differential Effects of Depleting versus Programming Tumor-Associated Macrophages on Engineered T Cells in Pancreatic Ductal Adenocarcinoma.

Stromnes IM, Burrack AL, Hulbert A, Bonson P, Black C, Brockenbrough JS, Raynor JF, Spartz EJ, Pierce RH, Greenberg PD, Hingorani SR.

Cancer Immunol Res. 2019 Jun;7(6):977-989. doi: 10.1158/2326-6066.CIR-18-0448. Epub 2019 Apr 26.

PMID:
31028033
3.

Interferon-gamma drives programmed death-ligand 1 expression on islet β cells to limit T cell function during autoimmune diabetes.

Osum KC, Burrack AL, Martinov T, Sahli NL, Mitchell JS, Tucker CG, Pauken KE, Papas K, Appakalai B, Spanier JA, Fife BT.

Sci Rep. 2018 May 29;8(1):8295. doi: 10.1038/s41598-018-26471-9.

4.

Simultaneous Recognition of Allogeneic MHC and Cognate Autoantigen by Autoreactive T Cells in Transplant Rejection.

Burrack AL, Landry LG, Siebert J, Coulombe M, Gill RG, Nakayama M.

J Immunol. 2018 Feb 15;200(4):1504-1512. doi: 10.4049/jimmunol.1700856. Epub 2018 Jan 8.

5.

T Cell-Mediated Beta Cell Destruction: Autoimmunity and Alloimmunity in the Context of Type 1 Diabetes.

Burrack AL, Martinov T, Fife BT.

Front Endocrinol (Lausanne). 2017 Dec 5;8:343. doi: 10.3389/fendo.2017.00343. eCollection 2017. Review.

6.

Cutting Edge: Allograft Rejection Is Associated with Weak T Cell Responses to Many Different Graft Leukocyte-Derived Peptides.

Burrack AL, Malhotra D, Dileepan T, Osum KC, Swanson LA, Fife BT, Jenkins MK.

J Immunol. 2018 Jan 15;200(2):477-482. doi: 10.4049/jimmunol.1701434. Epub 2017 Dec 18.

7.

Increased Effector Memory Insulin-Specific CD4+ T Cells Correlate With Insulin Autoantibodies in Patients With Recent-Onset Type 1 Diabetes.

Spanier JA, Sahli NL, Wilson JC, Martinov T, Dileepan T, Burrack AL, Finger EB, Blazar BR, Michels AW, Moran A, Jenkins MK, Fife BT.

Diabetes. 2017 Dec;66(12):3051-3060. doi: 10.2337/db17-0666. Epub 2017 Aug 25.

8.

Genetic ablation of arginase 1 in macrophages and neutrophils enhances clearance of an arthritogenic alphavirus.

Stoermer KA, Burrack A, Oko L, Montgomery SA, Borst LB, Gill RG, Morrison TE.

J Immunol. 2012 Oct 15;189(8):4047-59. doi: 10.4049/jimmunol.1201240. Epub 2012 Sep 12.

9.

Expression and regulation of chemokines in murine and human type 1 diabetes.

Sarkar SA, Lee CE, Victorino F, Nguyen TT, Walters JA, Burrack A, Eberlein J, Hildemann SK, Homann D.

Diabetes. 2012 Feb;61(2):436-46. doi: 10.2337/db11-0853. Epub 2011 Dec 30.

10.

Individual differences in susceptibility to experimentally induced phantom sensations.

Burrack A, Brugger P.

Body Image. 2005 Sep;2(3):307-13. Epub 2005 Aug 26.

PMID:
18089197
11.

Mitempfindung in synaesthetes: co-incidence or meaningful association?

Burrack A, Knoch D, Brugger P.

Cortex. 2006 Feb;42(2):151-4.

PMID:
16683488

Supplemental Content

Loading ...
Support Center